Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yangzhou Tianhe Pharmaceutical is a Chinese pharmaceutical company specializing in the development and manufacture of transdermal drug delivery systems and topical medicinal patches. Founded in 1988 and headquartered in Yangzhou, Jiangsu Province, the company established itself as a significant player in the Chinese external-use analgesic market with its "Tianhe" brand of medicated plasters. In 2012, the company was acquired by the Japanese pharmaceutical giant Hisamitsu Pharmaceutical for approximately 17.3 billion yen to serve as a strategic manufacturing and sales hub in China. The company's product portfolio primarily focuses on pain management for conditions such as arthritis, muscle aches, and joint injuries. Today, it operates as a wholly-owned subsidiary of Hisamitsu, integrating Japanese transdermal technology with local production expertise.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yangzhou Tianhe Pharmaceutical.